History
A 3-year-old 47.3-kg (104.1-lb) neutered male German Shepherd Dog was evaluated by a veterinary ophthalmologist because of blepharospasm of the left eye. One year prior to the evaluation, the dog had been transported to the United States from Egypt. At that time, the dog had a conjunctival and dermal transmissible venereal tumor (TVT). The patient was treated with vincristine chemotherapy and was reported by the owner to have achieved clinical remission.
Clinical and Gross Findings
With the exception of ocular abnormalities, findings on general physical examination were unremarkable. For the left eye, the pupillary light, menace, and dazzle reflexes were absent. There was marked conjunctival hyperemia, corneal edema, hyphema, hypopyon, and 4+ aqueous flare. The pupil was mydriatic with posterior synechiae. Because of the severe hyphema, hypopyon, and flare, no ocular structures posterior to the lens could be visualized. For the right eye, the pupillary light, menace, and dazzle reflexes were present. There were cellular opacities and fibrin strands in the vitreous humor, which obscured some of the temporal tapetal portion of the fundus.
Both the left-to-right and right-to-left indirect pupillary light reflexes were absent. The rest of the cranial nerve examination findings were considered normal. Results of a CBC, serum biochemical analysis, and thoracic radiography were unremarkable. A PCR assay failed to detect the DNA of Hepatozoon americanum and Hepatozoon canis in a blood sample obtained from the dog; results of serologic tests for circulating antibodies against Leishmania donovani, Babesia canis, Ehrlichia canis, Borrelia burgdorferi, Rickettsia rickettsii, and Aspergillus spp were all negative.
Because of the perceived pain and irreversible blindness associated with the dog's left eye, the left eye was enucleated, and the globe was submitted for histologic examination. Grossly, the external adnexal structures appeared normal and the cornea was cloudy. Hemisectioning of the globe revealed retinal detachment; hemorrhage in the anterior chamber, posterior chamber, vitreous humor, and subretinal space; and a soft tan-colored mass in the subretinal space (Figure 1)
Formulate differential diagnoses from the history, clinical findings, and Figure 1—then turn the page—
Histopathologic Findings
Histologically, a necrotic mass of neoplastic cells was present in the subretinal space of the enucleated left eye. The neoplastic cells multifocally carpeted the ciliary body, diffusely infiltrated the retina, and were mixed with the hemorrhage in the posterior chamber and vitreous humor (Figure 2) The neoplastic cells were round with distinct cell borders, and contained a small to moderate amount of finely vacuolated amphophilic cytoplasm, and a round to oval nucleus with clumped chromatin and a single variably prominent nucleolus. Cellular pleomorphism was mild. Mitotic figures were present in moderate numbers but difficult to quantify because of the multifocal distribution of the neoplasm throughout the globe. There was moderate hemorrhage in the anterior chamber, posterior chamber, vitreous humor, and subretinal space. Abundant lymphocytes and plasma cells had infiltrated the iris and ciliary body stroma. A fibrovascular membrane lined the anterior border of the iris and crossed the iridocorneal angle, forming peripheral anterior synechiae. The fibrovascular membrane continued across the anterior portion of the lens capsule resulting in posterior synechiae and formation of a pupillary membrane. There was severe liquefaction of cortical lens fibers that caused wrinkling of the lens capsule, and multifocal mineralization within the lens. The retina was diffusely detached and multifocally necrotic with perivascular accumulations of lymphocytes and plasma cells. A few lymphocytes and plasma cells diffusely had infiltrated the choroid. The optic nerve head was gliotic with mild hemorrhage.
Immunohistochemical Findings
Immunohistochemical analyses for CD3, CD20, CD204, CD117, and lysozyme were performed on specimens of the necrotic subretinal mass in the left globe. More than 90% of the neoplastic cells had moderately strong cytoplasmic reactivity to anti-lysozyme antibodies, and cells were uniformly negative for CD3, CD20, CD204, and CD117 (Figure 3), which strongly supported a diagnosis of TVT.
Morphologic Diagnosis and Case Summary
Morphologic diagnosis: metastatic TVT in the left eye, along with marked lymphoplasmacytic panuveitis with fibrovascular membrane and synechia formation, hypermature cataract, intraocular hemorrhage, retinal detachment and necrosis with lymphoplasmacytic retinitis, and chronic secondary glaucoma.
Case summary: intraocular metastasis of TVT in a dog.
Comments
Transmissible venereal tumor is 1 of 3 transmissible tumors known to develop in mammals; the others are contagious reticulum cell sarcoma of Syrian hamsters and devil facial tumor disease of Tasmanian devils. Transmissible venereal tumor is spread by implantation of tumor cells in a new host, most commonly during coitus.1 Most TVTs develop on genitalia, but these tumor cells can also be implanted on other mucosal surfaces (eg, oral, nasal, and conjunctival mucosae) and skin.2–4 The primary tumor forms cauliflower-like nodules that are often firm but friable, ulcerated, and hemorrhagic and are prone to secondary infection.1 For affected animals, the treatment of choice is IV administration of vincristine sulfate, which achieves permanent remission in most cases.5 Immunity against tumor cells generally prevents recurrence.1 Metastasis is uncommon (occurring in 5% of affected dogs) and usually transiently affects nearby lymph nodes.1 There are few case reports of intraocular metastasis of TVT.6,7 The tumor is endemic in at least 90 countries, but within the United States, cases are confined to populations of feral dogs in the Southwest.8
In the case described in the present report, the morphology of the TVT cells and the multifocal distribution of the neoplasm along with the carpeting of intraocular surfaces were highly suggestive of round cell tumor metastasis to the eye.9 The most common metastatic round cell tumors of the eye in dogs are histiocytic sarcoma and lymphoma. Cytologic examination is the preferred diagnostic test for TVT. For the dog of the present report, such testing was not performed prior to enucleation of the left eye because the owner elected to have the painful nonfunctional eye removed surgically independent of the diagnosis. Cytologically, TVT cells are round to oval with multiple clear cytoplasmic vacuoles, frequent mitotic figures, clumped chromatin, and 1 or 2 prominent nucleoli.10 The histologic appearance of TVT is more variable and cannot be solely used as the basis for a definitive diagnosis; immunohistochemical analyses of neoplastic tissue is required to rule out other round cell neoplasms.11
Immunohistochemical analyses for CD3, CD20, CD204, CD117, and lysozyme were performed in the case described in the present report. CD204 is expressed by tissue-resident macrophages and is a highly specific and sensitive marker for canine histiocytic sarcomas.12 CD3 is expressed by T lymphocytes, CD20 is expressed by B lymphocytes, CD117 is expressed by mast cells, and lysozyme is expressed by both TVT cells and histiocytes. For the dog of the present report, the neoplastic cells were positive for lysozyme but negative for CD3, CD20, CD204, and CD117. The immunohistochemical characteristics and morphology of the neoplastic cells and the dog's history of conjunctival TVT supported the diagnosis of ocular metastasis of TVT.
The neoplasm within the left globe led to numerous secondary intraocular changes. First, neoplastic cells and hemorrhage in the subretinal space resulted in retinal detachment. Because the lens is highly sensitive to changes in the aqueous humor and vitreous humor, neoplastic cells and necrosis within the posterior chamber and vitreous humor may have promoted cataract formation. The marked uveitis may have been secondary to the necrotic neoplasm or the cataract, or both. Fibrovascular membrane formation can occur secondary to uveitis, intraocular neoplasia, or retinal detachment, all of which were present in this dog. In the left globe, fibrovascular membranes extended from the base of the iris and across the iridocorneal angle (peripheral anterior synechiae), causing obstruction of the normal aqueous humor outflow with subsequent elevation of intraocular pressure and development of glaucoma.
The case described in the present report highlighted the importance of careful inspection for masses during gross examination of dogs with ocular problems; if an ocular mass is detected, histologic examination of the lesion for neoplastic cells should be undertaken. Thorough examination of ocular structures is especially important when a globe is filled with hemorrhage, which can obscure subtle abnormalities. In the case described in the present report, the mass was initially obscured by a pool of blood in the subretinal space. The mass was detected grossly only after blood had been cleared from the hemisected globe. Furthermore, the mass was small and largely necrotic, and viable neoplastic cells were sparsely distributed throughout the globe. Neoplastic cells that metasta-size to a globe are frequently sparsely distributed, and examination of deeper sections of the tumor are often required to fully evaluate the neoplastic cells.
For the dog of the present report, the postoperative recovery was without complication until approximately 3 months after globe enucleation, when the dog developed uveitis and acute blindness in its remaining right eye. The dog was treated with doxorubicin chemotherapy every 3 weeks along with systemic and intraocular administration of corticosteroids. Initially, the dog regained its sight, and clinical signs improved; however, 1.5 months after initiating chemotherapy, the dog developed intractable blindness in the right eye. Enucleation of the right eye was elected, and the globe was submitted for histologic examination. Histologically, a population of neoplastic cells morphologically identical to the neoplastic cells in the previously enucleated eye were found. A diagnosis of metastatic TVT to the right eye was made. Five months after the second surgery, the dog was apparently healthy and had no evidence of TVT recurrence.
For the dog of the present report, it is unclear why vincristine chemotherapy failed to achieve permanent remission of the TVT. Although permanent remission is achieved in most dogs with TVT following vincristine treatment, some authors have noted that the biological behavior of TVT is more aggressive in immunosuppressed dogs.1,6 However, the dog of the present report was systemically healthy and had no known evidence of immunosuppression. It is also possible that the intraocular concentration of chemotherapeutic agents was not adequate. To the authors' knowledge, intraocular concentrations of vincristine and doxorubicin following IV administration have not been evaluated in dogs. The specific sequence of events leading to bilateral intraocular metastasis of TVT in the dog of the present report was not known.
Acknowledgments
The authors declare that there were no conflicts of interest.
References
1. Ganguly B, Das U, Das AK. Canine transmissible venereal tumour: a review. Vet Comp Oncol 2016;14:1–12.
2. Komnenou AT, Thomas AL, Kyriazis AP, et al. Ocular manifestations of canine transmissible venereal tumour: a retrospective study of 25 cases in Greece. Vet Rec 2015;176:523–528.
3. Marcos R, Santos M, Marrinhas C, et al. Cutaneous transmissible venereal tumor without genital involvement in a prepubertal female dog. Vet Clin Pathol 2006;35:106–109.
4. Rogers KS, Walker MA, Dillon HB. Transmissible venereal tumor: a retrospective study of 29 cases. J Am Anim Hosp Assoc 1998;34:463–470.
5. Scarpelli KC, Valladão ML & Metze K. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy. Vet J 2010;183:362–363.
6. Ferreira AJ, Jaggy A, Varejão AP, et al. Brain and ocular metastases from a transmissible venereal tumour in a dog. J Small Anim Pract 2000;41:165–168.
7. Pereira JS, Silva AB, Martins AL, et al. Immunohistochemical characterization of intraocular metastasis of a canine transmissible venereal tumor. Vet Ophthalmol 2000;3:43–47.
8. Strakova A, Murchison EP. The changing global distribution and prevalence of canine transmissible venereal tumour. BMC Vet Res 2014;10:168.
9. Dubielzig RD. Metastases. In: Peiffer RL, Simons KB, eds. Ocular tumors in animals and humans. Ames, Iowa: Iowa State Press, 2002;337–378.
10. Duncan JR, Prasse KW. Cytology of canine cutaneous round cell tumors. Mast cell tumor, histiocytoma, lymphosarcoma and transmissible venereal tumor. Vet Pathol 1979;16:673–679.
11. MacLachlan NJ, Agnew DW. Tumors of the genital system. In: Meuten DJ, ed. Tumors in domestic animals. Ames, Iowa: John Wiley & Sons, 2017;698–722.
12. Kato Y, Murakami M, Hoshino Y, et al. The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma. J Comp Pathol 2013;148:188–196.
13. Marchal T, Chabanne L, Kaplanski C, et al. Immunopheno-type of the canine transmissible venereal tumour. Vet Immunol Immunopathol 1997;57:1–11.
14. Mendelsohn ME, Abramson DH, Madden T, et al. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol 1998;116:1209–1212.